Zavegepant | Interleukin Related interleukin-related.com

Product Name :
Zavegepant

Search keywords :
Vazegepant

drugId :
null

Target Vo:
Calcitonin gene-related peptide receptor

Target Vo Short Name :
CGRPR

Moa_Name:
Calcitonin gene-related peptide receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Pfizer Inc

Active Indication_Name:
Migraine Disorders

In Active Indication_Name:
Asthma

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKR Rabbit mAb Biological Activity
Vatelizumab Formula
Hexokinase I Antibody (YA739): Hexokinase I Antibody (YA739) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to Hexokinase I (6B8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts